Clinical Trial Update: Optimized Cord Blood Transplantation for the Treatment of Patients With High-risk Hematologic Malignancies Who Have Relapsed After First Allogeneic Stem Cell Transplantation [Phase 2]

View source ↗

Summary

This Phase 2 clinical trial evaluates optimized cord blood transplantation as a treatment for patients with high-risk hematologic malignancies who relapse after…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hematologic Malignancies

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Hematologic Malignancies | Phase 2 | Status: RECRUITING